# Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)

Study · id `cardio:ct-nct03278509` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03278509](<https://clinicaltrials.gov/study/NCT03278509>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03278509

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 5000 participants.

## Technical summary

Registry record NCT03278509. Randomized; no masking; primary purpose treatment. Start 2017-09-11 (actual); primary completion 2023-11-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 5000 participants (planned count; ClinicalTrials.gov record NCT03278509, source copy `cardio:ctgov-nct03278509-2024-03-05`, retrieved 2026-10-26)
- Started: 2017-09-11 (actual) (ClinicalTrials.gov record NCT03278509, source copy `cardio:ctgov-nct03278509-2024-03-05`, retrieved 2026-10-26)
- Primary completion: 2023-11-16 (actual) (ClinicalTrials.gov record NCT03278509, source copy `cardio:ctgov-nct03278509-2024-03-05`, retrieved 2026-10-26)
- Completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT03278509, source copy `cardio:ctgov-nct03278509-2024-03-05`, retrieved 2026-10-26)
- Countries: Sweden (ClinicalTrials.gov record NCT03278509, source copy `cardio:ctgov-nct03278509-2024-03-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03278509-2024-03-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
- Condition: Acute Myocardial Infarction
- Condition: Non-ST Elevation Myocardial Infarction
- Condition: ST Elevation Myocardial Infarction
- Intervention (Drug): Metoprolol Succinate
- Intervention (Drug): Bisoprolol
- Lead sponsor: Karolinska Institutet
- Lead sponsor class: OTHER
- Collaborator: Uppsala University
- Collaborator class: OTHER
- Collaborator: The Swedish Research Council
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Bisoprolol (`cardio:bisoprolol`)
- Registry intervention is a member of this class by a sourced record link: Beta-blockers (drug class) (`cardio:beta-blockers`)
- Registry lists this organization as the lead sponsor: Karolinska Institutet (`cardio:org-karolinska-institutet`)
- Registry lists this organization as a collaborator: Uppsala University (`cardio:org-uppsala-university`)
- Registry lists this organization as a collaborator: The Swedish Research Council (`cardio:org-the-swedish-research-council`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction (`cardio:pubmed-38587241`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Psychometric properties of the Swedish cardiac anxiety questionnaire: a Rasch analysis (`cardio:pubmed-41286053`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 40b44660011d9f717d246dd1c99d53f42e4c9b5bdc170dddb7205464d3860c5a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
